Last reviewed · How we verify
NCT03781453
POWERPLAY Phase 2: Development and Evaluation in Male-dominated Workplaces
NA trial testing POWERPLAY in Men in 498 participants. Completed in 7 February 2020.
7 February 2020
Quick facts
| Lead sponsor | Joan Bottorff |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 498 |
| Start date | 1 April 2019 |
| Primary completion | 7 February 2020 |
| Estimated completion | 7 February 2020 |
| Sites | 3 locations across Canada |
Drugs / interventions tested
- POWERPLAY
Conditions studied
- Men — all drugs for Men →
- Health Behavior — all drugs for Health Behavior →
- Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
- Health Knowledge, Attitudes, Practice — all drugs for Health Knowledge, Attitudes, Practice →
Sponsor
Joan Bottorff
Who can join
18 and older, male only, with Men or Health Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
With funding from the Alberta Ministry of Labour (Grant #095244772), a program called POWERPLAY (www.powerplayatwork.com), designed to promote men's health at work, will be evaluated in workplaces in Alberta.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Men's Physical Activity and Sleep Following a Workplace Health Intervention: Findings from the POWERPLAY STEP Up challenge.
Seaton CL, Bottorff JL, Soprovich AL, Johnson ST, et al · · 2021 · cited 2× · PMID 33622063 · DOI 10.1177/1557988320988472
Verify or expand the search:
- PubMed search for NCT03781453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of POWERPLAY
Trials testing the same drug.
- NCT03548077 — POWERPLAY: Promoting Men's Health at Work · NA · completed
Other recruiting trials for Men
Currently open trials in the same condition.
- NCT05927519 — Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study · NA · recruiting
- NCT05602376 — Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging · NA · recruiting
- NCT05927623 — Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men · NA · active not recruiting
- NCT04175678 — Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men · NA · active not recruiting
- NCT04530916 — Wild Blueberries and Cardiovascular Health in Middle-aged/Older Men and Postmenopausal Women · Phase 1, PHASE2 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03781453 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Joan Bottorff
- Last refreshed: 8 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03781453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing